Ark launches stomach cancer blood test for early stage stomach cancer detection
Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding. Ark ’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Cancer | Cancer & Oncology | Funding | Gastric (Stomach) Cancer | Information Technology | Singapore Health